Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Crosbie

Showing results (261-270 of 400) with videos related to

Pageof 40
Sort By:
Cancers|November 13, 2021
Does Clinical and Biochemical Thyroid Dysfunction Impact on Endometrial Cancer Survival Outcomes? A Prospective Database StudyChloe E Barr, Kelechi Njoku, Leo Hotchkies, et al.
Frontiers in Medicine|May 30, 2023
Immune checkpoint inhibitors efficacy across solid cancers and the utility of PD-L1 as a biomarker of response: a systematic review and meta-analysisTimothy S Fitzsimmons, Niharika Singh, Thomas D J Walker, et al.
International Journal of Women'S Health|February 4, 2022
Women's Risk Perceptions and Willingness to Engage in Risk-Reducing Interventions for the Prevention of Obesity-Related Endometrial CancerAbigail E Derbyshire, Michelle L MacKintosh, Christina M Pritchard, et al.
Frontiers in Immunology|January 31, 2020
Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial CancerNeal C Ramchander, Neil A J Ryan, Thomas D J Walker, et al.
Gynecologic Oncology|November 28, 2017
The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: A prospective case control studySarah J Kitson, Jennifer Lindsay, Vanitha N Sivalingam, et al.
Ebiomedicine|March 21, 2024
Detection of endometrial cancer in cervico-vaginal fluid and blood plasma: leveraging proteomics and machine learning for biomarker discoveryKelechi Njoku, Andrew Pierce, Davide Chiasserini, et al.
Gynecologic Oncology|May 1, 2018
The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancerC M Nagle, E J Crosbie, A Brand, et al.
British Journal of Cancer|January 23, 2016
Measuring the biological effect of presurgical metformin treatment in endometrial cancerV N Sivalingam, S Kitson, R McVey, et al.
Clinical Genetics|September 29, 2021
Dominant-negative pathogenic variant BRIP1 c.1045G>C is a high-risk allele for non-mucinous epithelial ovarian cancer: A case-control studyNicola Flaum, Elke M van Veen, Olivia Smith, et al.
Molecular Psychiatry|December 31, 2003
Glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 regionJ Adams, J Crosbie, K Wigg, et al.
Pageof 40

Showing results (261-270 of 400) with videos related to

Sort By:
Pageof 40
Cancers|November 13, 2021
Does Clinical and Biochemical Thyroid Dysfunction Impact on Endometrial Cancer Survival Outcomes? A Prospective Database StudyChloe E Barr, Kelechi Njoku, Leo Hotchkies, et al.
Frontiers in Medicine|May 30, 2023
Immune checkpoint inhibitors efficacy across solid cancers and the utility of PD-L1 as a biomarker of response: a systematic review and meta-analysisTimothy S Fitzsimmons, Niharika Singh, Thomas D J Walker, et al.
International Journal of Women'S Health|February 4, 2022
Women's Risk Perceptions and Willingness to Engage in Risk-Reducing Interventions for the Prevention of Obesity-Related Endometrial CancerAbigail E Derbyshire, Michelle L MacKintosh, Christina M Pritchard, et al.
Frontiers in Immunology|January 31, 2020
Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial CancerNeal C Ramchander, Neil A J Ryan, Thomas D J Walker, et al.
Gynecologic Oncology|November 28, 2017
The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: A prospective case control studySarah J Kitson, Jennifer Lindsay, Vanitha N Sivalingam, et al.
Ebiomedicine|March 21, 2024
Detection of endometrial cancer in cervico-vaginal fluid and blood plasma: leveraging proteomics and machine learning for biomarker discoveryKelechi Njoku, Andrew Pierce, Davide Chiasserini, et al.
Gynecologic Oncology|May 1, 2018
The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancerC M Nagle, E J Crosbie, A Brand, et al.
British Journal of Cancer|January 23, 2016
Measuring the biological effect of presurgical metformin treatment in endometrial cancerV N Sivalingam, S Kitson, R McVey, et al.
Clinical Genetics|September 29, 2021
Dominant-negative pathogenic variant BRIP1 c.1045G>C is a high-risk allele for non-mucinous epithelial ovarian cancer: A case-control studyNicola Flaum, Elke M van Veen, Olivia Smith, et al.
Molecular Psychiatry|December 31, 2003
Glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 regionJ Adams, J Crosbie, K Wigg, et al.
Pageof 40